GLAUKOS Corp Cost of Goods Sold (Deprecated 2018-01-31)
GLAUKOS Corp (GKOS) reported Cost of Goods Sold (Deprecated 2018-01-31) of $4.63 million for the 3-month period ending 2017-12-31, per its 10-K filed 2018-02-28.
Discontinued › Expense Statement
us-gaap:CostOfGoodsSold · last filed 2018-02-28
- GLAUKOS Corp cost of goods sold (deprecated 2018-01-31) for the quarter ending 2017-12-31 was $4.63M, a 3.76% decline year-over-year.
- GLAUKOS Corp cost of goods sold (deprecated 2018-01-31) for the quarter ending 2017-09-30 was $5.72M, a 47.14% increase year-over-year.
- GLAUKOS Corp cost of goods sold (deprecated 2018-01-31) for the quarter ending 2017-06-30 was $5.52M, a 26.68% increase year-over-year.
- GLAUKOS Corp cost of goods sold (deprecated 2018-01-31) for the quarter ending 2017-03-31 was $5.18M, a 65.97% increase year-over-year.
- GLAUKOS Corp cost of goods sold (deprecated 2018-01-31) for fiscal 2017 was $21.05M, a 30.12% increase from fiscal 2016.
- GLAUKOS Corp cost of goods sold (deprecated 2018-01-31) for fiscal 2016 was $16.18M, a 24.55% increase from fiscal 2015.
- GLAUKOS Corp cost of goods sold (deprecated 2018-01-31) for fiscal 2015 was $12.99M, a 13.75% increase from fiscal 2014.
- GLAUKOS Corp cost of goods sold (deprecated 2018-01-31) for fiscal 2014 was $11.42M, a 350.41% increase from fiscal 2013.
| Period end | Cost of Goods Sold (Deprecated 2018-01-31) 3 month | Cost of Goods Sold (Deprecated 2018-01-31) 6 month | Cost of Goods Sold (Deprecated 2018-01-31) 9 month | Cost of Goods Sold (Deprecated 2018-01-31) 12 month |
|---|---|---|---|---|
| 2017-12-31 | $4.63M 10-K · filed 2018-02-28 | $10.35M derived: sum of 2 quarters · filed 2018-02-28 | $15.87M derived: sum of 3 quarters · filed 2018-02-28 | $21.05M 10-K · filed 2018-02-28 |
| 2017-09-30 | $5.72M 10-K · filed 2018-02-28 | $11.24M derived: sum of 2 quarters · filed 2018-02-28 | $16.42M 10-Q · filed 2017-11-08 | $21.23M derived: sum of 4 quarters · filed 2018-02-28 |
| 2017-06-30 | $5.52M 10-K · filed 2018-02-28 | $10.70M 10-Q · filed 2017-08-07 | $15.51M derived: sum of 3 quarters · filed 2018-02-28 | $19.40M derived: sum of 4 quarters · filed 2018-02-28 |
| 2017-03-31 | $5.18M 10-K · filed 2018-02-28 | $9.99M derived: sum of 2 quarters · filed 2018-02-28 | $13.88M derived: sum of 3 quarters · filed 2018-02-28 | $18.24M derived: sum of 4 quarters · filed 2018-02-28 |
| 2016-12-31 | $4.81M 10-K · filed 2018-02-28 | $8.70M derived: sum of 2 quarters · filed 2018-02-28 | $13.06M derived: sum of 3 quarters · filed 2018-02-28 | $16.18M 10-K · filed 2018-02-28 |
| 2016-09-30 | $3.89M 10-K · filed 2018-02-28 | $8.24M derived: sum of 2 quarters · filed 2018-02-28 | $11.37M 10-Q · filed 2017-11-08 | $14.96M derived: sum of 4 quarters · filed 2018-02-28 |
| 2016-06-30 | $4.36M 10-K · filed 2018-02-28 | $7.48M 10-Q · filed 2017-08-07 | $11.07M derived: sum of 3 quarters · filed 2018-02-28 | $14.39M derived: sum of 4 quarters · filed 2018-02-28 |
| 2016-03-31 | $3.12M 10-K · filed 2018-02-28 | $6.71M derived: sum of 2 quarters · filed 2018-02-28 | $10.03M derived: sum of 3 quarters · filed 2018-02-28 | $13.31M derived: sum of 4 quarters · filed 2018-02-28 |
| 2015-12-31 | $3.59M 10-K · filed 2017-03-15 | $6.91M derived: sum of 2 quarters · filed 2017-03-15 | $10.19M derived: sum of 3 quarters · filed 2017-03-15 | $12.99M 10-K · filed 2018-02-28 |
| 2015-09-30 | $3.32M 10-K · filed 2017-03-15 | $6.60M derived: sum of 2 quarters · filed 2017-03-15 | $9.39M 10-Q · filed 2016-11-14 | $14.28M derived: sum of 4 quarters · filed 2017-03-15 |
| 2015-06-30 | $3.28M 10-K · filed 2017-03-15 | $6.08M 10-Q · filed 2016-08-04 | $10.96M derived: sum of 3 quarters · filed 2017-03-15 | $13.21M derived: sum of 4 quarters · filed 2017-03-15 |
| 2015-03-31 | $2.79M 10-K · filed 2017-03-15 | $7.68M derived: sum of 2 quarters · filed 2017-03-15 | $9.93M derived: sum of 3 quarters · filed 2017-03-15 | $12.27M derived: sum of 4 quarters · filed 2017-03-15 |
| 2014-12-31 | $4.89M 10-K · filed 2016-03-15 | $7.13M derived: sum of 2 quarters · filed 2016-03-15 | $9.47M derived: sum of 3 quarters · filed 2016-03-15 | $11.42M 10-K · filed 2017-03-15 |
| 2014-09-30 | $2.25M 10-K · filed 2016-03-15 | $4.58M derived: sum of 2 quarters · filed 2016-03-15 | $6.53M 10-Q · filed 2015-11-12 | |
| 2014-06-30 | $2.34M 10-K · filed 2016-03-15 | $4.28M 10-Q · filed 2015-08-13 | ||
| 2014-03-31 | $1.94M 10-K · filed 2016-03-15 | |||
| 2013-12-31 | $2.54M 10-K · filed 2016-03-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| INSULET CORP (PODD) | United States | $9.420B | 28.12 |
| GLOBUS MEDICAL INC (GMED) | United States | $9.977B | 20.03 |
| BAXTER INTERNATIONAL INC (BAX) | United States | $12.139B | -10.35 |
| MiniMed Group, Inc. (MMED) | United States | $5.748B | -16.85 |
| Penumbra Inc (PEN) | United States | $12.596B | 77.33 |
| MERIT MEDICAL SYSTEMS INC (MMSI) | United States | $5.212B | 28.44 |
| TELEFLEX INC (TFX) | United States | $5.093B | -5.44 |
| HAEMONETICS CORP (HAE) | United States | $4.821B | 36.52 |
| Heartflow, Inc. (HTFL) | United States | $4.225B | |
| ICU MEDICAL INC/DE (ICUI) | United States | $4.153B | 18.85 |